Fund Holdings — Fairmount Funds Management LLC

Total Portfolio Value:
$644.62M
Total Bought:
$0
Total Sold:
$215.87M
Net Transaction:
-$215.87M
Notable People:
Tomas Kiselak, Peter Evan Harwin
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Axsome Therapeutics, Inc.(AXSM)1,468,983815,176-653,807$124.29M$95.07M14.75%-$29.22M
Apogee Therapeutics Inc2,048,6472,048,6470$92.80M$76.54M11.87%-$16.27M
Spyre Therapeutics, Inc.(SYRE)4,018,1014,018,1010$93.54M$64.83M10.06%-$28.71M
Enliven Therapeutics Inc3,202,7983,202,7980$72.06M$63.03M9.78%-$9.03M
Nuvalent Inc1,317,664727,563-590,101$103.15M$51.60M8.00%-$51.55M
Dianthus Therapeutics, Inc.(DNTH)2,700,6912,700,6910$58.88M$48.99M7.60%-$9.88M
Viridian Therapeutics, Inc.(VRDN)3,445,8133,445,8130$66.06M$46.45M7.21%-$19.61M
Scholar Rock Holding Corporation(SRRK)1,962,9531,374,031-588,922$84.84M$44.18M6.85%-$40.66M
Cogent Biosciences, Inc.(COGT)6,225,6416,225,6410$48.56M$37.29M5.79%-$11.27M
Oruka Therapeutics, Inc.(ORKA)3,371,9223,371,9220$65.38M$34.60M5.37%-$30.79M
Kiniksa Pharmaceuticals International, plcCL A(KNSA)2,194,3411,102,248-1,092,093$43.40M$24.48M3.80%-$18.92M
Astria Therapeutics Inc3,554,1293,554,1290$31.77M$18.98M2.94%-$12.79M
Zenas BioPharma, Inc.(ZBIO)1,892,8061,892,8060$15.50M$14.95M2.32%-$548.9K
Inhibikase Therapeutics, Inc.(IKT)6,125,0006,125,0000$19.91M$13.41M2.08%-$6.49M
Bicara Therapeutics Inc1,284,169784,170-499,999$22.37M$10.22M1.59%-$12.15M
Anaptysbio Inc1,816,4660-1,816,466$24.05M$0—-$24.05M
Day One Biopharmaceuticals Inc
COM
3,103,4480-3,103,448$39.32M$0—-$39.32M
Page 1 of 1
Fairmount Funds Management LLC — 13F Holdings — Q1 2025 | TickerTrail